Ben-Gurion University researchers have developed a dynamic "smart" drug that targets inflammation in a site-specific manner and reduce side-effects. Study is reported in reported in the current issue of Journal of Immunology.
Ben-Gurion University researchers have developed a dynamic "smart" drug that targets inflammation in a site-specific manner and reduce side-effects. Study is reported in reported in the current issue of Journal of Immunology.
Cataracts are the most common cause of blindness in humans and account for half of blindness cases worldwide. Currently the only available treatment for the debilitating growths is surgery. It remains prohibitively costly. An eye drop tested on dogs suggests that cataracts could one day be cured without surgery. The study revealed that a naturally-occurring molecule called lanosterol, administered with an eye dropper, shrank canine cataracts. The study is found in Nature.
Ludwig Cancer Research scientists finds normal cells have highly selective mechanisms. But they found that some types of cancer cells aren't so selective. These cells incorporate chemically modified nucleosides into their DNA, which is toxic to them. The findings indicate that it might be possible to use modified nucleotides for specific killing of cancer cells. The study is published in the journal Nature.
Stomach cancer or gastric cancer is the third most common cause of death from cancer worldwide. A short course of two medicines, an antibiotic and another medicine that suppresses the production of gastric acid, that is commonly used to eliminate the bacterium may reduce the risk of stomach cancer, revealed a new research. The findings are published in the Cochrane Library.